Results 131 to 140 of about 8,688 (186)

Association of <i>DPP4</i> Gene Variants with Classic and DPP4 Inhibitor-Associated Bullous Pemphigoid. [PDF]

Int J Mol Sci
Achilla C, Foutsitzidou C, Meltzanidou P, Patsatsi A, Lazaridou E, Tzatzagou G, Lambropoulos A, Chatzikyriakidou A.   +7 more
europepmc   +1 more source

A Rare Case of Dupilumab Monotherapy in Pemphigoid Nodularis and a Comprehensive Literature Review. [PDF]

Cureus
Albthali SM, Alajmi FM, Almutairi S, Al-Sabah H.   +3 more
europepmc   +1 more source

Antituberculous Therapy-Induced Rare Skin Toxicity: Bullous Pemphigoid.

J Pharm Bioallied Sci
Patil RC, Krishnamurthy V, Prabhu D, Kumar SP.   +3 more
europepmc   +1 more source

Hemidesmosome Mutations Contribute to the Onset and Severity of Acquired Autoimmune Bullous Diseases. [PDF]

MedComm (2020)
Cao S, Wang T, Lv C, Ma S, Yu G, Xia Q, Liu T, Yu Y, Sun L, Pei X, Zhao Q, Wang Z, Wang C, Liu Y, Chen S, Wang J, Zhou G, Liu H, Sun Y, Zhang F.   +19 more
europepmc   +1 more source

CTLA-4 haploinsufficiency presenting with chronic myeloid leukemia, bullous pemphigoid, and PLA2R-positive membranous nephropathy: a case report. [PDF]

Allergy Asthma Clin Immunol
Deeb N, Deeb S, Ahmed FS, Amro YMY, Altell A, Khalili A.   +5 more
europepmc   +1 more source

Bullous eczema with hyaluronic acid deposition: A case report. [PDF]

JAAD Case Rep
Kohri N, Yatsuzuka K, Yoshida S, Nishihara K, Shiraishi K, Fujisawa Y, Muto J.   +6 more
europepmc   +1 more source

A case series of vildagliptin-associated bullous pemphigoid - Rare side effect.

Indian J Pharmacol
Shahi MK, Ashwin JV, Singh A, Gupta S, Surya K.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bullous pemphigoid

Nature Reviews Disease Primers
Bullous pemphigoid is a chronic, subepidermal autoimmune blistering disease characterized by tense blisters on erythematous or normal skin that predominantly affects the older population. The disease arises from autoantibodies targeting hemidesmosomal proteins BP180 and BP230, which are crucial for dermal-epidermal adhesion.
Hossein Akbarialiabad, Enno Schmidt, Aikaterini Patsatsi, Yen Loo Lim, Anisa Mosam, Kaisa Tasanen, Jun Yamagami, Maryam Daneshpazhooh, Dipankar De, Adela Rambi G. Cardones, Pascal Joly, Dedee F. Murrell   +11 more
  +7 more sources

Infantile bullous pemphigoid

European Journal of Dermatology, 2022
Bullous pemphigoid (BP) is relatively rare in the paediatric age group, with slightly more than 100 cases of BP reported in the literature. In this article, we focus on infantile BP (>= 28 days, <12 months), presenting a systematic review of cases of infantile BP in the literature from 1977 up to the present day. Fifty-four articles were selected,
Cozzani, Emanuele, Herzum, Astrid, Gasparini, Giulia, Viglizzo, Gianmaria, Parodi, Aurora   +4 more
openaire   +2 more sources

Bullous pemphigoid

Autoimmunity Reviews, 2017
Bullous pemphigoid (BP) is the most common autoimmune bullous disorder which is characterized by autoantibodies against hemidesmosomal proteins of the skin and mucous membranes. Collagen XVII and dystonin-e have been identified as target antigens. BP affects mostly the elderly. The incidence of the disease is increasing gradually and is associated with
Işın Sinem, Bağcı, Orsolya N, Horváth, Thomas, Ruzicka, Miklós, Sárdy   +3 more
openaire   +3 more sources